O
4.72
0.41 (9.51%)
| Previous Close | 4.31 |
| Open | 4.32 |
| Volume | 606,451 |
| Avg. Volume (3M) | 414,915 |
| Market Cap | 85,682,584 |
| Price / Sales | 0.420 |
| Price / Book | 0.570 |
| 52 Weeks Range | |
| Earnings Date | 10 Nov 2025 |
| Profit Margin | -98.73% |
| Operating Margin (TTM) | -54.86% |
| Diluted EPS (TTM) | -28.79 |
| Quarterly Revenue Growth (YOY) | 5.60% |
| Total Debt/Equity (MRQ) | 57.79% |
| Current Ratio (MRQ) | 8.37 |
| Operating Cash Flow (TTM) | -96.05 M |
| Levered Free Cash Flow (TTM) | -56.52 M |
| Return on Assets (TTM) | -17.41% |
| Return on Equity (TTM) | -86.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | Outset Medical, Inc. | Bearish | Bullish |
AIStockmoo Score
0.4
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | 0.38 |
|
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 2.69% |
| % Held by Institutions | 83.27% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Pfm Health Sciences, Lp | 30 Sep 2025 | 1,729,921 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 17.00 (BTIG, 260.17%) | Buy |
| 17.00 (RBC Capital, 260.17%) | Hold | |
| Median | 17.00 (260.17%) | |
| Low | 14.00 (Stifel, 196.61%) | Buy |
| Average | 16.00 (238.98%) | |
| Total | 2 Buy, 1 Hold | |
| Avg. Price @ Call | 6.22 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 11 Nov 2025 | 17.00 (260.17%) | Buy | 6.22 |
| RBC Capital | 11 Nov 2025 | 17.00 (260.17%) | Hold | 6.22 |
| Stifel | 11 Nov 2025 | 14.00 (196.61%) | Buy | 6.22 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 10 Nov 2025 | Announcement | Outset Medical Reports Third-Quarter Results |
| 05 Nov 2025 | Announcement | New Research Demonstrates the Advantages of an Insourced Dialysis Service Line for Acute-Care Facilities Using Outset Medical’s Tablo® Hemodialysis System |
| 05 Nov 2025 | Announcement | Outset Medical to Present at the 2025 Stifel Healthcare Conference |
| 27 Oct 2025 | Announcement | Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |